n-palmitoylsphingosine has been researched along with Disease Models, Animal in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Bielohuby, M; Bruning, JC; Brunner, B; Hansen, G; Larsen, PJ; Pfenninger, A; Raichur, S; Tennagels, N; Wang, B | 1 |
| Beiser, DG; Berdyshev, EV; Gorshkova, IA; Goya, J; Natarajan, V; Orbelyan, GA; Vanden Hoek, TL; Wang, H | 1 |
| Alsahli, A; Cremers, S; Gold, T; Jiang, H; Kiefhaber, K; Muluke, M; Schulze-Späte, U | 1 |
| Chan, M; Fuks, Z; García-Barros, M; Haimovitz-Friedman, A; Hambardzumyan, D; Kaag, M; Kolesnick, R; Stancevic, B; Truman, JP | 1 |
| Itoi, T; Oka, T; Terada, N | 1 |
6 other study(ies) available for n-palmitoylsphingosine and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach.
Topics: Adipose Tissue, Brown; Animals; Blood Glucose; Ceramides; Diabetes Mellitus, Type 2; Diet, High-Fat; Disease Models, Animal; Gene Knockdown Techniques; Hep G2 Cells; Humans; Insulin Resistance; Leptin; Liver; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Oligonucleotides, Antisense; Sphingosine N-Acyltransferase; Thionucleotides; Weight Gain | 2019 |
Inhibition of sphingosine-1-phosphate lyase rescues sphingosine kinase-1-knockout phenotype following murine cardiac arrest.
Topics: Aldehyde-Lyases; Animals; Cardiopulmonary Resuscitation; Ceramides; Chromatography, Liquid; Disease Models, Animal; Female; Gene Expression Regulation; Heart Arrest; Imidazoles; Lysophospholipids; Mice; Mice, Inbred C57BL; Mice, Knockout; Phosphotransferases (Alcohol Group Acceptor); Receptors, Lysosphingolipid; Signal Transduction; Spectrometry, Mass, Electrospray Ionization; Sphingosine; Sphingosine-1-Phosphate Receptors; Survival Rate; Tandem Mass Spectrometry | 2013 |
Palmitic Acid Reduces Circulating Bone Formation Markers in Obese Animals and Impairs Osteoblast Activity via C16-Ceramide Accumulation.
Topics: Absorptiometry, Photon; Animals; Biomarkers; Ceramides; Diet, High-Fat; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Male; Mice; Mice, Inbred C57BL; Obesity; Oleic Acid; Osteoblasts; Osteogenesis; Palmitic Acid | 2016 |
Endothelial membrane remodeling is obligate for anti-angiogenic radiosensitization during tumor radiosurgery.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Apoptosis; Cattle; Cell Line, Tumor; Ceramides; Disease Models, Animal; Endothelium; Female; Humans; Male; Mice; Mice, Knockout; Neoplasms; Radiation-Sensitizing Agents; Radiotherapy Dosage; Sphingomyelin Phosphodiesterase; Vascular Endothelial Growth Factor A | 2010 |
Modulation of C16:0-ceramide in hypertrophied immature hearts by losartan.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Aortic Valve Stenosis; Cardiomegaly; Ceramides; Disease Models, Animal; Heart Ventricles; Hypertrophy, Left Ventricular; Losartan; Myocardium; Rabbits | 2013 |